To advance the clinical application of immune tolerance by performing high quality clinical trials of emerging therapeutics integrated with mechanism-based research. In particular, we aim to: Establish new tolerance therapeutics Develop a better understanding of the mechanisms of immune function and disease pathogenesis Identify new biomarkers of tolerance and disease